SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-017521
Filing Date
2023-01-27
Accepted
2023-01-27 16:02:04
Documents
13
Period of Report
2023-01-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d379156d8k.htm   iXBRL 8-K 28376
  Complete submission text file 0001193125-23-017521.txt   202129

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbax-20230127.xsd EX-101.SCH 4778
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbax-20230127_def.xml EX-101.DEF 14791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbax-20230127_lab.xml EX-101.LAB 25194
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbax-20230127_pre.xml EX-101.PRE 15889
7 EXTRACTED XBRL INSTANCE DOCUMENT d379156d8k_htm.xml XML 7309
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 23562700
SIC: 6770 Blank Checks